The British Heart Foundation says that the use of statins is contributing to the reduction in number of people dying from heart disease in the UK. The BHF released data which indicate that statins cut the risk of coronary death by as much as 25%, saving an estimated 9,000 to 10,000 lives a year.
Roger Boyle, national director of heart disease and stroke at the UK Department of Health, said that, between 1996 and 2004, deaths from CVD fell around 36%, and that statin-based treatments were responsible for around 40% of this reduction.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze